RE: Bought1 Oct 2023 07:59
I don't know. Bought a year ago and really disappointed with performance since compared with the benchmark and competitors. My investment is down around 10% compared with a broadly flat benchmark. On a five-year view, BBH is down 3% compared with 45% gain from Polar Capital Healthcare and 12% gain from Worldwide Healthcare. The portfolio holdings are rather obscure, mid-cap (as opposed to large pharma) and very US-centric, which has been working against it.
Can't help thinking that the enhanced dividend is a red herring from a focus on total return (considering it just gets deducted from the trust's NAV). I've also grown somewhat weary of the VERY long and often tangental commentary from Mr Major that reads to me like smoke and mirrors to cover from poor performance.
Overall, I think I'll probably end up switching to the two aforementioned healthcare trusts which have a broader and more mainstream exposure - or simply buy something like the Legal & General Global Health & Pharmaceuticals Index that tracks the global index.